Real-world effectiveness of 20-valent pneumococcal conjugate vaccine against all-cause outcomes among Medicare beneficiaries aged 65 years and older in the USA: a retrospective cohort study.

Miles AC, Vojicic J, Peyrani P, Rosenstock S, Li H, Vietri JT, Yan Q, Randall AE, Zhao X, Zhu W, Zhao B, Zhou A, Jodar L, Gessner BD, Theilacker C, Moïsi JC, Balmer P, Grant LR, Cane A

Open source

DOI: 10.1016/s1473-3099(26)00115-5
Published: 2026 Aug
Container: The Lancet. Infectious diseases
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s1473-3099-26-00115-5,
  title = {Real-world effectiveness of 20-valent pneumococcal conjugate vaccine against all-cause outcomes among Medicare beneficiaries aged 65 years and older in the USA: a retrospective cohort study.},
  author = {Miles AC and Vojicic J and Peyrani P and Rosenstock S and Li H and Vietri JT and Yan Q and Randall AE and Zhao X and Zhu W and Zhao B and Zhou A and Jodar L and Gessner BD and Theilacker C and Moïsi JC and Balmer P and Grant LR and Cane A},
  year = {2026},
  journal = {The Lancet. Infectious diseases},
  doi = {10.1016/s1473-3099(26)00115-5},
  url = {https://doi.org/10.1016/s1473-3099(26)00115-5}
}

RIS

TY  - JOUR
TI  - Real-world effectiveness of 20-valent pneumococcal conjugate vaccine against all-cause outcomes among Medicare beneficiaries aged 65 years and older in the USA: a retrospective cohort study.
AU  - Miles AC
AU  - Vojicic J
AU  - Peyrani P
AU  - Rosenstock S
AU  - Li H
AU  - Vietri JT
AU  - Yan Q
AU  - Randall AE
AU  - Zhao X
AU  - Zhu W
AU  - Zhao B
AU  - Zhou A
AU  - Jodar L
AU  - Gessner BD
AU  - Theilacker C
AU  - Moïsi JC
AU  - Balmer P
AU  - Grant LR
AU  - Cane A
PY  - 2026
JO  - The Lancet. Infectious diseases
DO  - 10.1016/s1473-3099(26)00115-5
UR  - https://doi.org/10.1016/s1473-3099(26)00115-5
ER  -

APA

AC, M., J, V., P, P., S, R., H, L., JT, V., Q, Y., AE, R., X, Z., W, Z., B, Z., A, Z., L, J., BD, G., C, T., JC, M., P, B., LR, G., & A, C. (2026). Real-world effectiveness of 20-valent pneumococcal conjugate vaccine against all-cause outcomes among Medicare beneficiaries aged 65 years and older in the USA: a retrospective cohort study.. The Lancet. Infectious diseases. https://doi.org/10.1016/s1473-3099(26)00115-5

Source records

pubmed · retrieved 2026-09-27T15:03:41.451Z
europe-pmc · retrieved 2026-09-27T15:03:41.465Z